申请人:——
公开号:US20010018522A1
公开(公告)日:2001-08-30
Compound of formula (I):
1
wherein:
n is 0 or 1,
W represents —CO— or S(O)
q
and q is 0, 1 or 2,
G represents a G
1
, G
2
, G
3
or G
4
group as defined in the description,
Z represents alkyl, aryl, heteroaryl, arylalkyl, arylalkenyl, arylalkynyl, heteroarylakenyl, heteroarylalkynyl or heteroarylalkyl each optionally substituted,
A represents a grouping selected from -A
2
-, -A
1
-A
2
-, -A
2
-A
1
- and -A
1
-A
2
-A
1
- wherein A
1
is alkylene and A
2
represents phenylene, cycloalkylene, naphthylene or heteroarylene each optionally substituted,
R represents hydrogen, alkyl, aryl, heteroaryl, arylalkyl arylalkenyl, arylalkynyl, heteroarylakenyl, heteroarylalkynyl or heteroarylalkyl each optionally substituted,
R
1
represents alkyl, aryl, heteroaryle, arylalkyl arylalkenyl, arylalkynyl, heteroarylakenyl, heteroarylalkynyl or heteroarylalkyl each optionally substituted.
Medicinal products containing the same are useful as Neuropeptide Y receptor ligand.
化合物式(I)的复合物:1其中:n为0或1,W代表—CO—或S(O)q,q为0、1或2,G代表如说明书中所定义的G1、G2、G3或G4基团,Z代表烷基、芳基、杂芳基、芳基烷基、芳基烯基、芳基炔基、杂芳基烯基、杂芳基炔基或杂芳基烷基,每个基团都可以选择性地被取代,A代表从-A2-、-A1-A2-、-A2-A1-和-A1-A2-A1-中选择的一种基团,其中A1是烷基,A2代表苯基、环烷基、萘基或杂芳基,每个基团都可以选择性地被取代,R代表氢、烷基、芳基、杂芳基、芳基烷基、芳基烯基、芳基炔基、杂芳基烯基、杂芳基炔基或杂芳基烷基,每个基团都可以选择性地被取代,R1代表烷基、芳基、杂芳基、芳基烷基、芳基烯基、芳基炔基、杂芳基烯基、杂芳基炔基或杂芳基烷基,每个基团都可以选择性地被取代。含有该化合物的药物制剂可用作神经肽Y受体配体。